SLQT vs. ALHC, CS, SPNT, LMND, CLOV, TRUP, HG, FIHL, SKWD, and ROOT
Should you be buying SelectQuote stock or one of its competitors? The main competitors of SelectQuote include Alignment Healthcare (ALHC), Credit Suisse Group (CS), SiriusPoint (SPNT), Lemonade (LMND), Clover Health Investments (CLOV), Trupanion (TRUP), Hamilton Insurance Group (HG), Fidelis Insurance (FIHL), Skyward Specialty Insurance Group (SKWD), and Root (ROOT). These companies are all part of the "insurance" industry.
SelectQuote vs.
SelectQuote (NYSE:SLQT) and Alignment Healthcare (NASDAQ:ALHC) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.
Alignment Healthcare received 25 more outperform votes than SelectQuote when rated by MarketBeat users. Likewise, 62.92% of users gave Alignment Healthcare an outperform vote while only 45.59% of users gave SelectQuote an outperform vote.
In the previous week, Alignment Healthcare had 8 more articles in the media than SelectQuote. MarketBeat recorded 11 mentions for Alignment Healthcare and 3 mentions for SelectQuote. SelectQuote's average media sentiment score of 0.66 beat Alignment Healthcare's score of 0.42 indicating that SelectQuote is being referred to more favorably in the media.
34.6% of SelectQuote shares are owned by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are owned by institutional investors. 11.4% of SelectQuote shares are owned by company insiders. Comparatively, 6.6% of Alignment Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
SelectQuote has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500.
SelectQuote has a net margin of -3.45% compared to Alignment Healthcare's net margin of -5.84%. SelectQuote's return on equity of -15.00% beat Alignment Healthcare's return on equity.
SelectQuote has higher earnings, but lower revenue than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than SelectQuote, indicating that it is currently the more affordable of the two stocks.
SelectQuote currently has a consensus price target of $4.50, suggesting a potential upside of 0.67%. Alignment Healthcare has a consensus price target of $11.88, suggesting a potential downside of 20.67%. Given SelectQuote's higher probable upside, analysts plainly believe SelectQuote is more favorable than Alignment Healthcare.
Summary
Alignment Healthcare beats SelectQuote on 10 of the 19 factors compared between the two stocks.
Get SelectQuote News Delivered to You Automatically
Sign up to receive the latest news and ratings for SLQT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SelectQuote Competitors List
Related Companies and Tools
This page (NYSE:SLQT) was last updated on 1/25/2025 by MarketBeat.com Staff
Free SLQT Stock Alerts